BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens

Genome Biol. 2023 Aug 15;24(1):188. doi: 10.1186/s13059-023-03029-1.

Abstract

MHC-I-associated peptides deriving from non-coding genomic regions and mutations can generate tumor-specific antigens, including neoantigens. Quantifying tumor-specific antigens' RNA expression in malignant and benign tissues is critical for discriminating actionable targets. We present BamQuery, a tool attributing an exhaustive RNA expression to MHC-I-associated peptides of any origin from bulk and single-cell RNA-sequencing data. We show that many cryptic and mutated tumor-specific antigens can derive from multiple discrete genomic regions, abundantly expressed in normal tissues. BamQuery can also be used to predict MHC-I-associated peptides immunogenicity and identify actionable tumor-specific antigens de novo.

Keywords: Computational biology; Immunopeptidome; Major histocompatibility complex; Tumor antigens.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / genetics
  • Histocompatibility Antigens Class I
  • Humans
  • Neoplasms* / genetics
  • Peptides / genetics
  • Proteogenomics*
  • RNA

Substances

  • Antigens, Neoplasm
  • Histocompatibility Antigens Class I
  • Peptides
  • RNA

Grants and funding